Lung infections in cystic fibrosis: deriving clinical insight from microbial complexity
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Lower respiratory tract bacterial infections, such as those associated with cystic fibrosis lung disease, represent a major healthcare burden. Treatment strategies are currently informed by culture-based routine diagnostics whose limitations, including an inability to isolate all potentially clinically significant bacterial species present in a sample, are well documented. Some advances have resulted from the introduction of culture-independent molecular assays for the detection of specific pathogens. However, the application of bacterial community profiling techniques to the characterization of these infections has revealed much higher levels of microbial diversity than previously recognized. These findings are leading to a fundamental shift in the way such infections are considered. Increasingly, polymicrobial infections are being viewed as complex communities of interacting organisms, with dynamic processes key to their pathogenicity. Such a model requires an analytical strategy that provides insight into the interactions of all members of the infective community. The rapid advance in sequencing technology, along with protocols that limit analysis to viable bacterial cells, are for the first time providing an opportunity to gain such insight.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The real-time polymerase chain reaction
Kubista, M., Andrade, J. M., Bengtsson, M., Forootan, A., Jonák, J., Lind, K., Sindelka, R., Sjöback, R., Sjögreen, B., Strömbom, L., et al. (2006) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2005.12.007 · Cited by 1,515
Suau, A., Bonnet, R., Sutren, M., Godon, J.-J., Gibson, G. R., Collins, M. D., & Doré, J. (1999) · Applied and Environmental Microbiology · doi:10.1128/aem.65.11.4799-4807.1999 · Cited by 1,490
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients
Smith, E. E., Buckley, D. G., Wu, Z., Saenphimmachak, C., Hoffman, L. R., D’Argenio, D. A., Miller, S. I., Ramsey, B. W., Speert, D. P., Moskowitz, S. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602138103 · Cited by 1,319
Dispersing biofilms with engineered enzymatic bacteriophage
Lu, T. K., & Collins, J. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704624104 · Cited by 895
Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase
Hughes, K. A., Sutherland, I. W., & Jones, M. V. (1998) · Microbiology · doi:10.1099/00221287-144-11-3039 · Cited by 360
Effects of upper respiratory tract infections in patients with cystic fibrosis.
Collinson, J., Nicholson, K. G., Cancio, E., Ashman, J., Ireland, D. C., Hammersley, V, Kent, J., & O'Callaghan, C. (1996) · Thorax · doi:10.1136/thx.51.11.1115 · Cited by 173
RSV Mediates Pseudomonas aeruginosa Binding to Cystic Fibrosis and Normal Epithelial Cells
van Ewijk, B. E., Wolfs, T. F. W., Aerts, P. C., Van Kessel, K. P. M., Fleer, A., Kimpen, J. L. L., & Van Der Ent, C. K. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e3180332d1c · Cited by 113
Recurrent exacerbations affect FEV1 decline in adult patients with cystic fibrosis
Amadori, A., Antonelli, A., Balteri, I., Schreiber, A., Bugiani, M., & De Rose, V. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2008.09.024 · Cited by 64
Cited by
The role of bacterial biofilms in chronic infections
Bjarnsholt, T. (2013) · APMIS · doi:10.1111/apm.12099 · Cited by 1,080
Polymicrobial Interactions: Impact on Pathogenesis and Human Disease
Peters, B. M., Jabra-Rizk, M. A., O'May, G. A., Costerton, J. W., & Shirtliff, M. E. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00013-11 · Cited by 712
Decade-long bacterial community dynamics in cystic fibrosis airways
Zhao, J., Schloss, P. D., Kalikin, L. M., Carmody, L. A., Foster, B. K., Petrosino, J. F., Cavalcoli, J. D., VanDevanter, D. R., Murray, S., Li, J. Z., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120577109 · Cited by 599
Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities
van der Gast, C. J., Walker, A. W., Stressmann, F. A., Rogers, G. B., Scott, P., Daniels, T. W., Carroll, M. P., Parkhill, J., & Bruce, K. D. (2011) · The ISME Journal · doi:10.1038/ismej.2010.175 · Cited by 266
Self-citationBaldan, R., Cigana, C., Testa, F., Bianconi, I., De Simone, M., Pellin, D., Di Serio, C., Bragonzi, A., & Cirillo, D. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089614 · Cited by 163
“significantly impact upon clinical outcomes [1,7,13].”
Metadata
- Authors
- Rogers, G. B., Stressmann, F. A., Walker, A. W., Carroll, M. P., & Bruce, K. D.
- Venue
- Expert Review of Molecular Diagnostics
- Publisher
- Informa UK Limited
- Published
- 2010-03
- Volume
- 10
- Issue
- 2
- Pages
- 187-196
- ISSN
- 1473-7159 (ISSN-L)
- 1744-8352
- OpenAlex
- W2158342176
- Cited by
- 39
- References
- 8
- FWCI
- 4.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lung infections in cystic fibrosis: deriving clinical insight from microbial complexity. https://app.cochat.ai/papers/10.1586/erm.09.81
- The paper
- Rogers, G. B., Stressmann, F. A., Walker, A. W., Carroll, M. P., & Bruce, K. D. (2010). Lung infections in cystic fibrosis: deriving clinical insight from microbial complexity. Expert Review of Molecular Diagnostics. https://doi.org/10.1586/erm.09.81
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.